# Saptaparna (Alstonia scholaris)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/saptaparna
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-20
**Evidence Score:** 2 / 10
**Category:** Ayurveda
**Also Known As:** Alstonia scholaris, Devil Tree, Blackboard Tree, Milky Pine, White Cheesewood, Shaitan ka Jhar, Chatian

## Overview

Saptaparna (Alstonia scholaris) contains indole alkaloids including alstonine and echitamine that demonstrate antimalarial and antibacterial properties. These compounds work primarily through enzyme inhibition and membrane disruption mechanisms in pathogenic organisms.

## Health Benefits

• Potential utility in treating malaria and abdominal disorders (preclinical evidence) • Shows moderate antibacterial activity against Salmonella typhimurium and Escherichia coli (in vitro) • Exhibits [anti-inflammatory](/ingredients/condition/inflammation) properties via alkaloids (preclinical studies) • Demonstrates [antioxidant activity](/ingredients/condition/antioxidant) comparable to BHA and ascorbic acid (animal models) • Traditional use in Ayurveda for fever, dysentery, asthma, and bronchitis (historical evidence)

## Mechanism of Action

Saptaparna's indole alkaloids, particularly alstonine and echitamine, inhibit key enzymes in malarial parasites and disrupt bacterial cell membrane integrity. The [anti-inflammatory](/ingredients/condition/inflammation) effects occur through inhibition of cyclooxygenase and lipoxygenase pathways. Antioxidant activity is mediated by [free radical scaveng](/ingredients/condition/antioxidant)ing through phenolic compounds in the bark extract.

## Clinical Summary

Current evidence for saptaparna is limited to preclinical studies and in vitro research. Laboratory studies show moderate antibacterial activity against Salmonella typhimurium and E. coli with MIC values ranging from 125-250 μg/mL. Animal studies demonstrate antimalarial effects, but sample sizes are typically small (10-20 subjects). No large-scale human clinical trials have been conducted to establish therapeutic efficacy or optimal dosing protocols.

## Nutritional Profile

Saptaparna (Alstonia scholaris) is not consumed as a food or dietary source; therefore, conventional macronutrient data (protein, fat, carbohydrate, fiber per serving) are not applicable. Its pharmacological relevance lies in its rich bioactive phytochemical profile: **Alkaloids (primary bioactive class, ~1.5–2.5% w/w in dried bark):** • Echitamine (major indole alkaloid, ~0.3–0.8% in bark) – key contributor to anti-malarial and [anti-inflammatory](/ingredients/condition/inflammation) activity • Alstonine (~0.1–0.4%) – reported sedative and antipsychotic properties • Scholaricine, picrinine, and vallesamine – present in lower concentrations (~0.05–0.2% each) • Total alkaloid content in leaves is generally lower (~0.5–1.2% w/w). **Triterpenoids & Steroids:** • Lupeol (~0.02–0.1% in bark extract) – anti-inflammatory and [hepatoprotective](/ingredients/condition/detox) • β-sitosterol (~0.01–0.05%) – cholesterol-modulating phytosterol • Ursolic acid (trace amounts in leaves). **Flavonoids & Phenolics:** • Total phenolic content in methanolic bark extract: ~45–85 mg gallic acid equivalents (GAE)/g extract • Total flavonoid content: ~20–40 mg quercetin equivalents (QE)/g extract • Specific compounds include kaempferol and quercetin glycosides (trace to low concentrations). **Iridoids & Glycosides:** • Loganin and sweroside identified in leaf extracts (concentrations not well-quantified but detected via HPLC). **Tannins:** • Present at ~2–5% w/w in bark, contributing to astringent and [antimicrobial](/ingredients/condition/immune-support) properties. **Minerals (in leaf/bark ash analysis):** • Calcium (~1.2–1.8% dry weight), Potassium (~0.8–1.5%), Magnesium (~0.3–0.6%), Iron (~150–350 ppm), Zinc (~30–60 ppm), Manganese (~40–80 ppm). **Vitamins:** • No significant vitamin content documented; not a relevant source. **Bioavailability notes:** • Indole alkaloids such as echitamine show moderate oral bioavailability in animal models due to hepatic first-pass [metabolism](/ingredients/condition/weight-management); alkaloid absorption is pH-dependent and enhanced in acidic gastric conditions. • Phenolic compounds have limited bioavailability (~5–10% estimated) unless formulated with absorption enhancers. • Traditional Ayurvedic preparations (kwath/decoction of bark) partially address bioavailability by prolonged aqueous extraction, which improves solubilization of polar alkaloid salts. • Lipophilic triterpenoids (lupeol, β-sitosterol) require co-administration with fats or lipid-based formulations for meaningful absorption.

## Dosage & Preparation

Traditional Ayurvedic dosages include 20–80 ml of bark decoction daily or 1–1.5 g of bark powder per day. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Saptaparna may cause gastrointestinal upset, nausea, and dizziness at higher doses due to its alkaloid content. The herb may interact with anticoagulant medications and antidiabetic drugs by enhancing their effects. Pregnant and breastfeeding women should avoid use due to lack of safety data and potential alkaloid toxicity. Individuals with liver conditions should use caution as indole alkaloids may affect hepatic [metabolism](/ingredients/condition/weight-management).

## Scientific Research

There are no human clinical trials, randomized controlled trials, or meta-analyses available for Alstonia scholaris. Evidence is limited to preclinical studies and traditional uses, as noted in a PubMed review (PMID: 22457172).

## Historical & Cultural Context

In Ayurveda, Saptaparna has been used for millennia to treat various conditions such as fever, asthma, and skin diseases. It is believed to balance Kapha and Pitta doshas with its bitter and astringent properties.

## Synergistic Combinations

Tulsi, Ashwagandha, Turmeric, Ginger, Neem

## Frequently Asked Questions

### What is the recommended dosage of saptaparna extract?

Traditional Ayurvedic texts suggest 3-6 grams of bark powder daily, though standardized clinical dosing has not been established. Most commercial extracts recommend 500-1000mg twice daily with meals.

### How long does it take for saptaparna to show antimalarial effects?

Animal studies show antimalarial activity within 4-7 days of treatment initiation. However, human efficacy timelines have not been clinically established and should not replace proven antimalarial medications.

### Can saptaparna be taken with blood pressure medications?

Saptaparna may interact with antihypertensive drugs due to its alkaloid content affecting cardiovascular function. Consult a healthcare provider before combining with blood pressure medications to avoid hypotensive episodes.

### What are the main active compounds in saptaparna bark?

The primary bioactive compounds are indole alkaloids including alstonine, echitamine, and scholaricine, typically comprising 0.8-1.5% of dried bark extract. These alkaloids are responsible for the antimicrobial and anti-inflammatory effects.

### Is saptaparna effective against antibiotic-resistant bacteria?

Laboratory studies show moderate activity against standard bacterial strains, but research on antibiotic-resistant organisms is limited. Current evidence does not support saptaparna as a replacement for proven antibiotic treatments.

### Is saptaparna safe during pregnancy and breastfeeding?

There is insufficient clinical evidence to establish the safety of saptaparna supplementation during pregnancy and breastfeeding, and it should be avoided during these periods as a precaution. Traditional use does not substitute for modern safety data, and pregnant or nursing individuals should consult a healthcare provider before use. Animal studies suggest potential effects on various organ systems, but human pregnancy safety studies are lacking.

### How does saptaparna compare to other traditional antimalarial herbs like artemisia?

While saptaparna shows promising antimalarial activity in preclinical studies, artemisia annua (the source of artemisinin) has significantly more robust clinical trial data supporting its antimalarial efficacy in human populations. Saptaparna's traditional use for fever and malaria-like conditions is documented in Ayurveda, but direct comparative clinical trials between the two herbs are limited. Artemisia remains the evidence-based choice for malaria treatment, whereas saptaparna may have complementary anti-inflammatory and fever-reducing applications.

### What does current clinical research show about saptaparna's effectiveness in humans?

Most evidence for saptaparna's benefits comes from in vitro and animal model studies, with limited human clinical trials available in peer-reviewed literature. The antimalarial, antibacterial, and anti-inflammatory properties demonstrated in preclinical research have not been thoroughly validated in large-scale human studies. While traditional Ayurvedic use spanning centuries suggests potential clinical value, more rigorous randomized controlled trials in human populations are needed to establish efficacy and appropriate dosing protocols.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*